XML 23 R5.htm IDEA: XBRL DOCUMENT v3.24.3
Consolidated Balance Sheets - USD ($)
$ in Millions
Oct. 27, 2024
Oct. 29, 2023
Current assets:    
Cash and cash equivalents $ 8,022 $ 6,132
Short-term investments 1,449 737
Accounts receivable, net 5,234 5,165
Inventories 5,421 5,725
Other current assets 1,094 1,388
Total current assets 21,220 19,147
Long-term investments 2,787 2,281
Property, plant and equipment, net 3,339 2,723
Goodwill 3,732 3,732
Purchased technology and other intangible assets, net 249 294
Deferred income taxes and other assets 3,082 2,552
Total assets 34,409 30,729
Current liabilities:    
Short-term debt 799 100
Accounts payable and accrued expenses 4,820 4,297
Contract liabilities 2,849 2,975
Total current liabilities 8,468 7,372
Long-term debt 5,460 5,461
Income taxes payable 670 833
Other liabilities 810 714
Total liabilities 15,408 14,380
Commitments and contingencies (Note 13)
Stockholders’ equity:    
Preferred stock: $0.01 par value per share; 1 shares authorized; no shares issued 0 0
Common stock: $0.01 par value per share; 2,500 shares authorized; 818 and 833 shares outstanding at 2024 and 2023, respectively 8 8
Additional paid-in capital 9,660 9,131
Retained earnings 49,651 43,726
Treasury stock: 1,211 and 1,191 shares at 2024 and 2023, respectively (40,150) (36,299)
Accumulated other comprehensive loss (168) (217)
Total stockholders’ equity 19,001 16,349
Total liabilities and stockholders’ equity $ 34,409 $ 30,729